Quest Diagnostics's most recent trend suggests a bullish bias. One trading opportunity on Quest Diagnostics is a Bull Put Spread using a strike $55.00 short put and a strike $45.00 long put offers a potential 9.29% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $55.00 by expiration. The full premium credit of $0.85 would be kept by the premium seller. The risk of $9.15 would be incurred if the stock dropped below the $45.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Quest Diagnostics is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Quest Diagnostics is bullish.
The RSI indicator is at 72.04 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Quest Diagnostics
CLFS review potential negative for Quest, LabCorp, says Piper Jaffray
Tue, 18 Mar 2014 11:28:50 GMT
QUEST DIAGNOSTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme
Mon, 17 Mar 2014 20:57:25 GMT
Quest Diagnostics Has An Improved Outlook After Summit Health Acquisition And $600 Million Refinancing
Thu, 13 Mar 2014 13:39:39 GMT
Quest Diagnostics to Buy Summit Health
Wed, 12 Mar 2014 20:00:04 GMT
Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
Wed, 12 Mar 2014 15:51:06 GMT
noodls – MADISON, N.J., March 12, 2014 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer $600,000,000 …
Related Posts
Also on Market Tamer…
Follow Us on Facebook